Sangrix Inc.

Sangrix Inc.(SGRX)の財務

$0.458

+0.046 (+9.98%)終値時点

SGRX の同業比較

In the context of the broader market, SGRX competes directly with industry leaders such as STKH and LWAY. With a market capitalization of $1.67M, it holds a significant position in the sector. When comparing efficiency, SGRX's gross margin of N/A stands against STKH's N/A and LWAY's 19.27%. Such benchmarking helps identify whether Sangrix Inc is trading at a premium or discount relative to its financial performance.

Sangrix Inc. の財務パフォーマンス

Sangrix Inc has reported a negative net income of -$2,770,979 for Q3 2026, with a current ratio of 44.93 indicating high liquidity but poor profitability. The company has a total debt of $14,433,480 against a negative equity position, which raises serious concerns about its financial health.

Financials

FY2024Q1
4.20M
Total Revenue
FY2026Q3
-2.77M
Operating Profit
FY2026Q3
-2.77M
Net Income after Tax
FY2026Q3
-417.76K
Free Cash Flow

関連記事

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める